Skip to content

Techniques for Abdominoplasty After Massive Weight Loss

Different Techniques for Abdominoplasty After Massive Weight Loss: Safety and Outcomes

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04805424
Enrollment
0
Registered
2021-03-18
Start date
2023-01-31
Completion date
2025-06-30
Last updated
2023-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin; Excess

Keywords

Randomized controlled trial, Abdominoplasty, Massive weight loss, Plastic surgery, Liposuction

Brief summary

Excess skin on the abdomen is a common problem for many individuals after massive weight loss. The surgical procedure of abdominoplasty is intended to remove excess skin and improve the shape of the torso in abdomen, in order to address issues such as skin fold eczema, difficulties finding clothing, and psychosocial issues. The investigators will conduct a randomized, controlled trial where individuals with excess skin on the abdomen will be randomized to either standard abdominoplasty or abdominoplasty in combination with liposuction. The investigators will examine the rate of complications, and the functional and aesthetical outcomes of the two methods.

Interventions

PROCEDURELipo-abdominoplasty

Abdominoplasty plus liposuction

PROCEDUREAbdominoplasty

Abdominoplasty

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

This study is open only to individuals who are residents in Sweden and qualify for government-funded, inpatient, non-emergency health care within the Stockholm Region. Inclusion Criteria: * BMI \< 30 * Stable BMI for \>= 6 months * \>= 24 months since bariatric surgery, if applicable * Skin fold of \>= 5 cm * Functional and/or psychosocial issues due to abdominal skin excess

Exclusion criteria

* Smoking * Ongoing infection

Design outcomes

Primary

MeasureTime frameDescription
Number of and type of complications within 30 days30 daysNumber of and type of complications occurring within 30 days of surgery

Secondary

MeasureTime frameDescription
Average need for analgesia in morphine equivalentsPost-operative day 1Average need for analgesia in morphine equivalents during post-operative day 1
Average score on BodyQ scoreAt baseline, at 3 months post-operatively, at 12 months post-operativelyAverage score on BodyQ score including subscales. BodyQ is developed and owned by Memorial Sloan Kettering Cancer Center. The BODY-Q is composed of 27 independently functioning scales that measure 3 overarching constructs Appearance, Quality of Life and Experience of Care. Scales are translated to a 0-100 score where a lower score means worse outcome.
Average score on aesthetic resultAt 12 months post-operativelyAverage score on aesthetic result on a 1-10 scale where a lower score means worse outcome.
Average days until dischargeDaysAverage days until discharge post-operatively

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026